Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 239 | 217 | 249 | 320 | 349 | 347 | 369 | 495 | 449 | 541 | | 572 |
% Growth | NA | -9.3% | 14.9% | 28.7% | 9.2% | -0.6% | 6.2% | 34.2% | -9.3% | 20.4% | | |
| | | | | | | | | | | | |
Cost of Revenue | (186) | (171) | (177) | (248) | (279) | (262) | (285) | (401) | (347) | (384) | | (400) |
Gross Profit | 53 | 45 | 72 | 72 | 71 | 85 | 84 | 94 | 102 | 156 | | 172 |
% Revenue | 22.1% | 20.8% | 28.9% | 22.6% | 20.2% | 24.6% | 22.8% | 19.1% | 22.7% | 28.9% | | 30.1% |
| | | | | | | | | | | | |
Research and Development | (9) | (9) | (9) | (11) | (10) | (11) | (15) | (16) | (16) | (21) | | (21) |
Selling and Marketing | (12) | (11) | (14) | (20) | (22) | (23) | (26) | (34) | (38) | (46) | | (49) |
General and Admin | (24) | (27) | (28) | (35) | (33) | (41) | (43) | (40) | (51) | (75) | | (82) |
Other Inc / (Exp) | 11 | 12 | 8 | 3 | 11 | 13 | 15 | 17 | 24 | 28 | | 31 |
Total Operating Exp | (35) | (35) | (44) | (63) | (54) | (62) | (68) | (73) | (81) | (114) | | (121) |
| | | | | | | | | | | | |
Operating Income | 18 | 10 | 28 | 10 | 17 | 24 | 16 | 21 | 21 | 43 | | 51 |
% Revenue | 7.4% | 4.7% | 11.4% | 3.1% | 4.9% | 6.8% | 4.2% | 4.3% | 4.7% | 7.9% | | 8.9% |
| | | | | | | | | | | | |
Interest Expense | (2) | (4) | (3) | (2) | (2) | (1) | (6) | (7) | (9) | (10) | | (9) |
Pre-tax Income | 15 | 6 | 25 | 8 | 15 | 22 | 10 | 15 | 12 | 33 | | 42 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (3) | (1) | (4) | (1) | (1) | (3) | (0) | (1) | (0) | (5) | | (6) |
Net Income to Company | 13 | 5 | 21 | 7 | 14 | 19 | 9 | 14 | 12 | 28 | | 37 |
% Margin | 5.4% | 2.5% | 8.3% | 2.2% | 3.9% | 5.5% | 2.5% | 2.7% | 2.7% | 5.2% | | 6.4% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 12 | 5 | 21 | 7 | 14 | 19 | 9 | 14 | 12 | 28 | | 37 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 12 | 5 | 21 | 7 | 14 | 19 | 9 | 14 | 12 | 28 | | 37 |
% Margin | 5.2% | 2.5% | 8.3% | 2.2% | 3.9% | 5.5% | 2.5% | 2.7% | 2.7% | 5.2% | | 6.4% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.03 | 0.01 | 0.06 | 0.02 | 0.03 | 0.04 | 0.02 | 0.03 | 0.02 | 0.06 | | 0.07 |
Diluted EPS (Continuing Ops) | 0.03 | 0.01 | 0.06 | 0.02 | 0.03 | 0.04 | 0.02 | 0.03 | 0.02 | 0.06 | | 0.07 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 375.00 | 375.00 | 375.00 | 432.53 | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 | 499.91 | | 499.91 |
WA Diluted Shares Out. | 375.00 | 375.00 | 375.00 | 432.53 | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 | 499.91 | | 499.91 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 15 | 6 | 25 | 8 | 15 | 22 | 10 | 15 | 12 | 33 | | 42 |
Addback: Net Interest Expense | 2 | 4 | 3 | 2 | 2 | 1 | 6 | 7 | 9 | 10 | | 9 |
Addback: Other Non Operating Expenses, Total | 1 | (3) | (2) | 3 | (1) | 0 | 3 | 2 | (1) | (1) | | (0) |
Addback: Depreciation & Amortization | 7 | 10 | 10 | 10 | 12 | 14 | 15 | 18 | 26 | 33 | | 33 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (1) | 0 | 0 | 0 | 1 | 0 | 0 | (0) | (0) | (0) | | (0) |
Addback: Gain (Loss) On Sale Of Assets | 1 | 0 | 1 | 0 | (0) | 0 | 0 | 1 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 7 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 26 | 17 | 45 | 32 | 30 | 38 | 34 | 42 | 46 | 75 | | 84 |
% Margin | 10.9% | 8.0% | 17.9% | 10.1% | 8.6% | 10.9% | 9.2% | 8.6% | 10.3% | 13.8% | | 14.7% |
| | | | | | | | | | | | |
Adjusted EBIT | 19 | 8 | 34 | 22 | 18 | 24 | 19 | 24 | 20 | 42 | | 51 |
% Margin | 7.8% | 3.5% | 13.7% | 6.9% | 5.0% | 6.9% | 5.2% | 4.9% | 4.5% | 7.7% | | 8.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 13 | 5 | 21 | 7 | 14 | 19 | 9 | 14 | 12 | 28 | | 37 |
Addback: Unusual Items | 0 | 0 | 8 | 10 | 1 | 0 | 0 | 1 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | (0) | (0) | (2) | (3) | (0) | 0 | (0) | (0) | (0) | (0) | | (0) |
Adjusted Net Income | 13 | 5 | 27 | 14 | 15 | 19 | 9 | 14 | 12 | 28 | | 37 |
% Margin | 5.5% | 2.5% | 10.7% | 4.4% | 4.2% | 5.5% | 2.6% | 2.8% | 2.7% | 5.3% | | 6.4% |